OCTOBER 25-26, 2011 | SAN FRANCISCO
EARLY BIRD REGISTRATION ENDS SEPTEMBER 16TH!
Register Now
Celebrating “A Decade of Excellence,” The 10th Annual BIO Investor Forum will bring together hundreds of leading investors and private and early stage biotech companies in San Francisco in October.
They will be scheduling private One-on-One meetings and participating in numerous networking opportunities, therapeutic workshops, business roundtables, and plenary sessions offering essential knowledge for investors and biotech company executives including…
• Immunotherapy: Heal Thyself
• Drug Development: Beyond the ABCs of ADCs
• Diagnostics: X Marks the Spot - Companion Dx in Oncology
• Infectious Disease: Resistance is Futile – SuperDrugs for Superbugs
For an up-to-date listing, see the Preliminary Program.
Advisory Committee:
John Chambers, Managing Director & Head of Healthcare
Investment Banking, Roth Capital Markets
Annette Grimaldi, Managing Director, BMO Capital Markets
James I. Healy, MD, PhD, General Partner, Sofinnova Ventures, LLC
Adam Koppel, MD, PhD, Managing Director, Brookside Capital, LLC
Ronald W. Lennox, DPhil, Founder, CHL Medical Partners, LLC
Gail Maderis, President & CEO, BayBio
Gwen A. Melincoff, SVP, Business Development Strategic
Investment Group, Shire Pharmaceuticals, Inc.
Jeffrey M. Ostrove, PhD, President & Chief Executive Officer,
Ceregene Inc.
Andrew J. Schwab, Founder & Managing Partner, 5AM Ventures, LLC
Katya Smirnyagina, PhD, Venture Partner, Alta Partners, LLC
Samuel Wu, MD, PhD, Managing Director, MedImmune Ventures
Asish K. Xavier, PhD, Vice President, Johnson & Johnson
Development Corporation
Sponsors:
Supporting Bank Sponsors:
BMO Capital Markets
Rodman & Renshaw LLC
Roth Capital
BIO Double Helix:
Abbott
Amgen Ventures
Eli Lilly and Company
Janssen Pharmaceutical
Companies of
Johnson & Johnson
Merck
BIO Helix:
GlaxoSmithKline
Conference Sponsors:
Campbell Alliance
VWR International
Special Pre-Conference Event
BIO Technology Transfer Symposium
October 24, 1 p.m. - 4 p.m.,
The Palace Hotel
Commercialization and Job Creation in the Biotechnology Sector:
What Does it Really Take?
At a moment when the U.S. is looking to encourage technology job growth, an increasing number of public and private sector initiatives have been proposed to spur job creation. While the U.S. leads in the area of biotechnology, there is no guarantee that this competitive edge will continue. Moreover, although the U.S. generates more life science discoveries than any other single country in the world, there is a sense that many of these discoveries do not make it to the market place. Experts believe that it is through commercialization of these early-stage discoveries, that the U.S. will be able to jump start job creation.
This public policy focused-forum will explore such proposals and initiatives through the lens of a biotechnology innovator/entrepreneur. Leaders in state, federal and regional governments, academia, industry and non-profit philanthropic organizations will discuss how they propose to translate early-stage discoveries into jobs, products and ultimately economic growth.
To attend, RSVP to Roy Zwahlen at rzwahlen@bio.org.
Hotel Information:
The Palace Hotel
2 New Montgomery Street
San Francisco, CA 94105
Housing for the BIO Investor Forum is now open. To receive the discounted $309.00 single/double occupancy rate please mention that you are attending BIO Investor Forum when securing accommodations. All hotel reservations must be received by September 29, 2011, to receive the discounted rate.
Click here for more information on accommodations at the Palace Hotel.
Click here to register now! http://www3.bio.org/investorforum/attend/registration/
